Workflow
Lassonde Industries Inc. announces its Q3-2025 results
Globenewswire· 2025-11-07 06:10
ROUGEMONT, Quebec, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced its financial results for the third quarter of 2025. Financial Highlights: Third quarters endedSept. 27, 2025Sept. 28, 2024∆(in millions of dollars, unless otherwise indicated)$$$Sales<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1 ...
SWK Holdings Corporation Announces Financial Results for Third Quarter 2025
Accessnewswire· 2025-11-07 06:10
Corporate Highlights Third quarter 2025 GAAP net income was $8.8 million, compared with GAAP net income of $3.5 million for the third quarter 2024. Third quarter 2025 income before tax expense was $10.7 million, compared with net income before tax expense of $4.4 million for the third quarter 2024. ...
Lowey Dannenberg Notifies Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
Globenewswire· 2025-11-07 06:10
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) for violations of the federal securities laws on behalf of all persons and entities who purchased or acquired Six Flags common stock pursuant or traceable to the Company’s registration statement and prospectus (“Registration Statement”) is ...
Tesla shareholders approve Elon Musk's historic $1 trillion pay package — here's when he could pocket the windfall
New York Post· 2025-11-07 06:09
Tesla shareholders approved an epic $1 trillion pay package for Elon Musk on Thursday – after the mercurial boss threatened to leave the company if he didn’t get it.The eye-popping compensation is the largest on record and could make Musk the world’s first trillionaire — although he’ll first have to hit a series of performance targets that stretch across the next decade. The 54-year-old is already the world’s richest person with a fortune of $490.1 billion, according to Forbes.Stock will be awarded to Musk ...
Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth - Buy (ACB)
Seeking Alpha· 2025-11-07 06:08
We also offer income-focused picks for those who prefer lower-risk firms with steady dividend payouts. Our 10-year track record proves the ability of our analyst team to outperform across all market conditions.Value Investor's Edge provides the world's best energy, shipping, and offshore market research. Over the past decade, we have achieved an annualized return of almost 40% with a long-only model portfolio return of over 23x.I have covered Aurora Cannabis Inc. or "Aurora Cannabis" ( ACB , ACB:CA ) previo ...
Duolingo Inc (NASDAQ: DUOL) Targets Significant Growth Amid Market Volatility
Financial Modeling Prep· 2025-11-07 06:08
Ryan MacDonald from Needham sets a price target of $300 for Duolingo Inc (NASDAQ: DUOL), indicating a potential increase of approximately 62.7%.The company reports a 40% increase in revenue and improved profit margins in the third quarter, underscoring its strong financial performance.Despite a nearly 25% drop in stock price on Thursday morning, Duolingo's market capitalization and trading volume highlight its significant presence and potential for recovery in the edtech sector.Duolingo Inc (NASDAQ: DUOL) i ...
Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth - Buy
Seeking Alpha· 2025-11-07 06:08
We also offer income-focused picks for those who prefer lower-risk firms with steady dividend payouts. Our 10-year track record proves the ability of our analyst team to outperform across all market conditions.Value Investor's Edge provides the world's best energy, shipping, and offshore market research. Over the past decade, we have achieved an annualized return of almost 40% with a long-only model portfolio return of over 23x.I have covered Aurora Cannabis Inc. or "Aurora Cannabis" ( ACB , ACB:CA ) previo ...
Saratoga Investment Corp. Announces New $85 Million Credit Facility with Valley National Bank
Globenewswire· 2025-11-07 06:08
To Replace Existing $65 Million Encina Credit Facility at Lower Spreads NEW YORK, NY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE: SAR) (“Saratoga Investment” or the “Company”), a business development company (“BDC”), today announced that it has entered into a new $85 million senior secured revolving credit facility (the “Valley Facility”) with Valley National Bank as SOLE LEAD ARRANGER AND ADMINISTRATIVE AGENT, together with three additional participating banks. The Valley Facility r ...
AI Valuation Concerns Drag Down U.S. Markets; Earnings Reports Fuel Individual Stock Swings
Stock Market News· 2025-11-07 06:07
U.S. equity markets experienced a notable downturn on Thursday, November 6, 2025, as resurgent worries over artificial intelligence (AI) valuations weighed heavily on investor sentiment. All three major indexes closed lower, marking a shift from earlier mixed trading sessions. The tech-heavy Nasdaq Composite led the declines, falling 1.9%, while the benchmark S&P 500 dropped 1.1%, and the blue-chip Dow Jones Industrial Average shed 0.8%. This broad-market retreat underscores a cautious mood as investors scr ...
DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
Prnewswire· 2025-11-07 06:07
Accessibility StatementSkip Navigation Phase 3 AQUILA study showed DARZALEX FASPRO significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring  Landmark approval supports earlier intervention and disease interception of multiple myeloma for the first time HORSHAM, Pa., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO (daratumumab and hyaluronidase ...